Altered hepatic gluconeogenesis during L-alanine infusion in weight-losinglung cancer patients as observed by phosphorus magnetic resonance spectroscopy and turnover measurements

Citation
S. Leij-halfwerk et al., Altered hepatic gluconeogenesis during L-alanine infusion in weight-losinglung cancer patients as observed by phosphorus magnetic resonance spectroscopy and turnover measurements, CANCER RES, 60(3), 2000, pp. 618-623
Citations number
45
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
60
Issue
3
Year of publication
2000
Pages
618 - 623
Database
ISI
SICI code
0008-5472(20000201)60:3<618:AHGDLI>2.0.ZU;2-I
Abstract
Profound alterations in host metabolism in lung cancer patients with weight loss have been reported, including elevated phosphomonoesters (PMEs) as de tected by P-31 magnetic resonance spectroscopy (MRS). In healthy subjects, infusion of L-alanine induced significant increases in hepatic PMEs and pho sphodiesters (PDEs) due to rising concentrations of 3-phosphoglycerate and phosphoenolpyruvate, respectively, The aim of the present study was to moni tor these changes in the tumor-free liver of lung cancer patients during L- alanine infusion by means of simultaneous P-31 MRS and turnover measurement s, Twenty-one lung cancer patients without liver metastases with (CaWL) or without weight loss (CaWS), and 12 healthy control subjects were studied du ring an i.v. L-alanine challenge of 1.4-2.8 mmol/kg followed by 2.8 mmol/kg /h for 90 min. Plasma L-alanine concentrations increased during alanine inf usion, from 0.35-0.37 mM at baseline to 5.37 +/- 0.14 mM in the CaWL patien ts, 6.67 +/- 0.51 mM in the CaWS patients, and 8.47 +/- 0.88 mM in the cont rols (difference from baseline and between groups during alanine infusion, all P < 0.001). Glucose turnover and liver PME levels at baseline were sign ificantly elevated in the CaWL patients. Alanine infusion increased whole-b ody glucose turnover by 8 +/- 3% in the CaWS patients (P = 0.03), whereas n o significant change occurred in the CaWL and controls. PME levels increase d by 50 +/- 16% in controls (area under the curve, P < 0.01) and by 87 +/- 31% in the CaWS patients (P < 0.05) after 45-90 min, In contrast, no signif icant changes in PME levels were observed in the CaWL patients. Plasma insu lin concentrations increased during L-alanine infusion in all groups to lev els that were lower in the CaWL patients than in the CaWS patients and cont rols (P < 0.05), In lung cancer patients, but not in controls, changes in P ME and PDE levels during alanine infusion mere inversely correlated with th eir respective baseline levels (r = -0.82 and -0.86, respectively; P < 0.00 1). In addition, changes in PMEs during alanine infusion in lung cancer pat ients were inversely correlated with the degree of weight loss (r = -0.54; P < 0.05), This study demonstrates the presence of major alterations in the pathway of hepatic gluconeogenesis in weight-losing lung cancer patients, as shown by elevated glucose flux before and during L-alanine infusion, and by the increased PME and PDE levels, which reflect accumulation of glucone ogenic intermediates in these patients, Weight-stable lung cancer patients show accelerated increases in PME and PDE levels during L-alanine infusion, suggesting enhanced induction of the gluconeogenic pathway. Our results su ggest altered gluconeogenic enzyme activities and elevated alanine uptake w ithin the livers of weight-losing/weight-stable lung cancer patients.